Psychiatry - December 2008 - (Page 41)

65. 66. 67. 68. 69. 70. 71. 72. 73. 74. 75. Neurology. 2002;59:744–746. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol. 1996;39:285–294. European Study Group on interferon B-1b in secondary progressive MS: placebo-controlled multicentre randomized trial of interferon B-1b in treatment of secondary progressive multiple sclerosis. Lancet. 1998;352:1491–1497. Patten SB, Fridhandler S, Beck CA, Metz LM. Depressive symptoms in a treated multiple sclerosis cohort. Mult Scler. 2003;9(6):616–620. Walff AA, Sumida K, Frye CA. Inhibiting 5alpha-reductase in the amygdale attenuates antianxiety and antidepressive behavior of naturally receptive and hormoneprimed ovariectomized rats. Psychopharmacology. 206;186(3):302–311. Altomare G, Capella GL. Depression circumstantially related to the administration of finasteride for andrgenetic alopecia. J Dermatol. 2002;29:665–669. Rahimi-Ardabili B, Pourandarjani R, Habibollahi P, Mualeki A. Finasteride induced depression: a prospective study. BMC Clin Pharmacol. 2006;6:7. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol. 2001;45:515–519. Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. N Engl J Med. 2001;344:460. Azoulay L, Blais L, Koren G, et al. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry. 2008;69:526–532. Hersom K, Neary MP, Levaux HP, et al. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. J Am Acad Dermatol. 2003;49:424–432. No authors Listed. Manufacturer moves to settle Norplant claims. 76. 77. 78. 79. 80. 81. 82. 83. 84. 85. Contracept Technol Update. 1999;20(11):129–130. Olsson SE, Odlind V, Johansson ED, Sivin I. Contraception with NORPLANT implants and NORPLANT-2 implants (two covered rods). Results from a comparative clinical study in Sweden. Contraception. 1988;37(1):61–73. Wagner KD, Berenson AB. Norplant-associated major depression and panic disorder. J Clin Psychiatry. 1994;55(11):478–480. Wagner KD. Major depression and anxiety disorders associated with Norplant. J Clin Psychiatry. 1996;57(4):152–157. Westhoff C, Truman C, Kalmuss D, et al. Depressive symptoms and Norplant contraceptive implants. Contraception. 1998;57(4):241–245. Stevens-Simon C, Kelly L, Wallis J. The timing of Norplant insertion and postpartum depression in teenagers. J Adolesc Health. 2000;26(6):408–413. Elovainio M, Teperi J, Aalto AM, et al. Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system. Int J Behav Med. 2007;14(2):70–75. Netherlands Pharmacovigilence Center. Montelukast and depressive symptoms. http://www.lareb.nl/documents/kwb _2006_4_montel.pdf. Accessed August 31, 2008. US Food and Drug Administration. Early communication about an ongoing safety review of montelukast (Singulair). http://www.fda.gov/cder/drug/early _comm/montelukast.htm. Accessed September 10, 2008. Holbrook JT, Harik-Khan R. Montelukast and emotional wellbeing as a marker for depression: results from 3 randomized, doublemasked clinical trials. J Allergy Clin Immunol. 2008;122(4):828–829. Gift AF, Wood RM, Cahill CA. Depression, somatization and [VOLUME 5, 86. 87. 88. 89. 90. 91. 92. steroid use in chronic obstructive pulmonary disease. Int J Nurs Stud. 1989;26(3):281–286. Patten SB, Williams JV, Love EJ. Self-reported depressive symptoms following treatment with corticosteroids and sedativehypnotics. Int J Psychiatry Med. 1996;26:15–24. Patten SB, Williams JV, Love EJ. A case-control study of corticosteroid exposure as a risk factor for clinically diagnosed depressive disorders in a hospitalized population. Can J Psychiatry. 1995;40(7):396–400. Feng L, Tan CH, Merchant RA, Ng TP. Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H2 receptor antagonists in community-dwelling older patients. Drugs Aging. 2008;25(9):795–805. US Food and Drug Administration. Varenicline (marketed as Chantix) information. http://www.fda.gov/cder/drug/infop age/varenicline/default.htm. Access date: September 30, 2008. Federal Aviation Administration. Anti-smoking medicine Chantix banned. http://www.faa.gov/news/updates/? newsId=56363. Access date: September 30, 2008. Popkin MK. Exacerbation of recurrent depression as a result of treatment with varenicline. Am J Psychiatry. Am J Psychiatry. 2008;165(6):774. Tsai ST, Cho HJ, Cheng HS et al. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. Clin Ther. 2007;29:1027–1039. NUMBER 12, DECEMBER] Psychiatry 2008 41 http://www.fda.gov/cder/drug/infopage/varenicline/default.htm http://www.fda.gov/cder/drug/infopage/varenicline/default.htm http://www.faa.gov/news/updates/?newsId=56363 http://www.faa.gov/news/updates/?newsId=56363 http://www.lareb.nl/documents/kwb_2006_4_montel.pdf http://www.lareb.nl/documents/kwb_2006_4_montel.pdf http://www.fda.gov/cder/drug/early_comm/montelukast.htm http://www.fda.gov/cder/drug/early_comm/montelukast.htm

Table of Contents Feed for the Digital Edition of Psychiatry - December 2008

Psychiatry - December 2008 Editor’s Message Contents Editorial Advisory Board Antidepressant Prescribing by Specialty and Treatment of Premenstrual Dysmorphic Disorder Pain, Pain, Go Away: Antidepressants and Pain Management Why Psychotherapy Helps the Patient in Chronic Pain General Medical Drugs Associated with Depression Katatonia: A New Conceptual Understanding of Catatonia and a New Rating Scale Thermoregulation and the Role of Calcium Signalling in Neurotransmission Cognition and Schizophrenia: Is There a Role for Cognitive Assessments in Diagnosis and Treatment? Journal Watch Information for Authors

Psychiatry - December 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.